[Neoadjuvant and adjuvant radiochemotherapy for rectal carcinoma].
The current standard treatment for resectable tumours in clinical stages II and III is neoadjuvant radio(chemo)therapy. Improved radiation techniques and chemotherapy (CT) with continuous infusion of 5-FU during adjuvant radiotherapy (RT) has led to an additional improvement of adjuvant therapeutic results. The efficacy of new cytostatic drugs and antibodies is presently being clinically tested for perioperative therapy.
Seegenschmiedt
Michael Heinrich
MH
Klinik für Radioonkologie und Strahlentherapie, Alfried Krupp Krankenhaus, Essen. silberfuchs_55km@web.de
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D007432:Intraoperative Period; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011379:Prognosis; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D015996:Survival Rate
D000970:Antineoplastic Agents